Details of the Drug

General Information of Drug (ID: DMH8IO5)

• Drug Name: Odetiglucan
• Synonyms: Imprime

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Phase 1	[1]

• Drug Type: Antibody
• Cross-matching ID: TTD ID: DLCX50

References

• [1] ClinicalTrials.gov (NCT05484011) P1b, Open-Label, Safety, Tolerability, Efficacy Study of a Soluble Beta-glucan Odetiglucan in Combination w/ a CD40 Agonist (CDX-1140) in Patients w/ Metastatic Pancreatic Adenocarcinoma Whose Disease Did Not Progress During 1st-Line Chemo. U.S.National Institutes of Health.